electroCore, Inc. (NASDAQ:ECOR – Get Free Report) CFO Joshua Lev sold 6,667 shares of the firm’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $9.00, for a total value of $60,003.00. Following the sale, the chief financial officer owned 84,889 shares of the company’s stock, valued at $764,001. The trade was a 7.28% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
electroCore Price Performance
NASDAQ:ECOR opened at $9.76 on Friday. electroCore, Inc. has a fifty-two week low of $4.16 and a fifty-two week high of $10.27. The stock’s 50-day moving average is $6.60 and its two-hundred day moving average is $6.10. The stock has a market cap of $80.97 million, a PE ratio of -5.51 and a beta of 0.68.
electroCore (NASDAQ:ECOR – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported ($0.59) earnings per share for the quarter, meeting the consensus estimate of ($0.59). electroCore had a negative return on equity of 1,956.38% and a negative net margin of 44.08%.The company had revenue of $9.58 million for the quarter, compared to analysts’ expectations of $9.01 million. On average, equities research analysts anticipate that electroCore, Inc. will post -1.48 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
ECOR has been the topic of several research reports. Zacks Research upgraded shares of electroCore from a “strong sell” rating to a “hold” rating in a research note on Friday, March 27th. upgraded shares of electroCore to a “strong-buy” rating in a research note on Tuesday, February 3rd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of electroCore in a research note on Friday, March 27th. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $18.00.
Get Our Latest Analysis on electroCore
About electroCore
electroCore, Inc is a commercial-stage bioelectronic medicine company headquartered in Rockaway, New Jersey. The company specializes in the development and commercialization of non-invasive vagus nerve stimulation (nVNS) therapies designed to address a variety of neurological and inflammatory conditions. Established in 2006, electroCore has focused its efforts on translating neuromodulation science into a compact, patient-administered treatment device.
The company’s lead product, gammaCore®, is a handheld, battery-powered device that delivers nVNS through the skin to the cervical branch of the vagus nerve.
Further Reading
- Five stocks we like better than electroCore
- MongoDB’s AI Advantage Is Starting to Show Up in Results
- MarketBeat Week in Review – 05/25 – 05/29
- Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
- Salesforce Stock Finds Support as AI Momentum Builds
Receive News & Ratings for electroCore Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for electroCore and related companies with MarketBeat.com's FREE daily email newsletter.
